Exendin-4 as a multi-target therapy for Fetal Inflammatory Response Syndrome-induced brain injury.

Li S, Cai C, Arigong G

DOI: 10.3389/fneur.2026.1848474
Published: 2026
Container: Frontiers in neurology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fneur.2026.1848474,
  title = {Exendin-4 as a multi-target therapy for Fetal Inflammatory Response Syndrome-induced brain injury.},
  author = {Li S and Cai C and Arigong G},
  year = {2026},
  journal = {Frontiers in neurology},
  doi = {10.3389/fneur.2026.1848474},
  url = {https://doi.org/10.3389/fneur.2026.1848474}
}

RIS

TY  - JOUR
TI  - Exendin-4 as a multi-target therapy for Fetal Inflammatory Response Syndrome-induced brain injury.
AU  - Li S
AU  - Cai C
AU  - Arigong G
PY  - 2026
JO  - Frontiers in neurology
DO  - 10.3389/fneur.2026.1848474
UR  - https://doi.org/10.3389/fneur.2026.1848474
ER  -

APA

S, L., C, C., & G, A. (2026). Exendin-4 as a multi-target therapy for Fetal Inflammatory Response Syndrome-induced brain injury.. Frontiers in neurology. https://doi.org/10.3389/fneur.2026.1848474

Source records

pubmed · retrieved 2026-09-26T10:36:58.956Z